Home » Stocks » CNTG

Centogene N.V. (CNTG)

Stock Price: $11.14 USD -0.76 (-6.39%)
Updated Oct 28, 2020 2:29 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 243.53M
Revenue (ttm) 54.81M
Net Income (ttm) -20.66M
Shares Out 21.86M
EPS (ttm) -1.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $11.14
Previous Close $11.90
Change ($) -0.76
Change (%) -6.39%
Day's Open 11.79
Day's Range 10.75 - 11.79
Day's Volume 120,422
52-Week Range 7.80 - 28.71

More Stats

Market Cap 243.53M
Enterprise Value 227.66M
Earnings Date (est) Apr 29, 2021
Ex-Dividend Date n/a
Shares Outstanding 21.86M
Float 6.12M
EPS (basic) n/a
EPS (diluted) -1.46
FCF / Share 0.75
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 6.10%
Payout Ratio n/a
Shares Short 260,489
Short Ratio 1.32
Short % of Float 4.26%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 16.38
PS Ratio 4.44
PB Ratio 5.27
Revenue 54.81M
Operating Income -20.99M
Net Income -20.66M
Free Cash Flow 14.86M
Net Cash 15.87M
Net Cash / Share 0.73
Gross Margin 46.69%
Operating Margin -38.30%
Profit Margin -42.30%
FCF Margin 27.12%
ROA -18.31%
ROE -99.71%
ROIC -32.30%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 3
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$22.50*
(101.97% upside)
Low
21.0
Current: $11.14
High
24.0
Target: 22.50
*Average 12-month USD price target from 4 stock analysts.

Financial Performance

Financial numbers in millions EUR.

Financial Overview

Year2019201820172016
Revenue48.7840.4831.6927.67
Revenue Growth20.51%27.74%14.53%-
Gross Profit22.7820.5416.7514.81
Operating Income-18.68-10.61-4.46-4.94
Net Income-20.66-10.97-5.35-5.22
Shares Outstanding19.8619.86--
Earnings Per Share-1.30-0.80-0.40-25.00
Operating Cash Flow-7.78-4.58-4.341.39
Capital Expenditures21.00-8.71-15.50-7.74
Free Cash Flow13.23-13.29-19.84-6.35
Cash & Equivalents41.109.223.16-
Total Debt26.9719.6819.34-
Net Cash / Debt14.13-10.46-16.18-
Assets11876.6755.49-
Liabilities57.6549.3938.75-
Book Value59.8627.2816.74-
Numbers in millions EUR, except per-share numbers.

Company Profile

Company Details

Full Name Centogene N.V.
Country Germany
Employees 440

Stock Information

Ticker Symbol CNTG
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: CNTG
IPO Date November 7, 2019

Description

Centogene N.V., together with its subsidiaries, engages in diagnosis and research around rare diseases that transform clinical and genetic data into information for patients, physicians, and pharmaceutical companies. Its platform analyzes epidemiologic, phenotypic, and genetic data to enhance the understanding of rare hereditary diseases. The company operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.